COVID-19 Assay Volume Quarterly Demand Outlook to December 2021 with Molecular, Serology Breakouts and Q1/Q2/Q3 Actual Volume Data
November 2020 edition including Molecular/Serology breakouts, with Q1/Q2/Q3 actual volume data
Rapid diagnostics is key to epidemic management, however the demand is staggering. Will it stagger the diagnostics industry? Our new report looks at the assay volume demands by country, looking out 5 quarters to the end of 2021. We look at 3 scenarios for pandemic progression and explore diagnostic demand in each scenario.
Our forecasts are based on the WHO Health Security Index with specific assumptions about the effectiveness of distancing measures and the impact of health system overload on different countries. These create varying timelines of demand. Demand that is not met in many cases.
If a country forecast is not already listed, purchasers can request individual country market size information, or other customization without additional charge with the corporate license.
Subscribe and Save
By signing up for the annual subscription, updates to this report will be automatically provided free of charge for a period of one year from initial purchase. These updates can include revised forecasts as markets increase or contract and exclusive market commentary not seen anywhere else. With the effects of COVID-19 being felt across all markets it has never been more crucial to stay fully informed with real-world actionable data. Subscribe to this report and receive ongoing market forecasting and analysis for sharpened strategic planning throughout the year.
- Quarterly report updates
- Summary of significant developments and market changes
- Phone consultation and assistance on request for the duration of the subscription
ABOUT THE LEAD AUTHOR
Mr. Greg Powell, B.SC., M.B.A is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell’s education includes:
- B.Sc. (Chemistry) University of BC
- M.B.A. (Finance and Policy) University of BC
- Market Research Seminar - Burke Institute
- Finance for Senior Executives - Harvard Business School